Τίτλος:
Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Dimopoulou, D.
Spyridis, N.
Vartzelis, G.
Tsolia, M.N.
Maritsi, D.N.
Περιοδικό:
Arthritis and Rheumatology
Εκδότης:
John Wiley and Sons Inc
Λέξεις-κλειδιά:
adalimumab; antirheumatic agent; etanercept; methotrexate; tumor necrosis factor inhibitor, adolescent; adverse event; arthralgia; disease exacerbation; fatigue; female; headache; human; injection site reaction; juvenile rheumatoid arthritis; male; myalgia; prevention and control; young adult, Adalimumab; Adolescent; Antirheumatic Agents; Arthralgia; Arthritis, Juvenile; BNT162 Vaccine; COVID-19; Disease Progression; Etanercept; Fatigue; Female; Headache; Humans; Injection Site Reaction; Male; Methotrexate; Myalgia; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Young Adult
